# Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

> **NCT00189176** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 23 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Tetrathiomolybdate

## Key facts

- **NCT ID:** NCT00189176
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189176, "Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00189176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*